171 related articles for article (PubMed ID: 27896225)
1. The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors.
Rossi FW; Prevete N; Rivellese F; Napolitano F; Montuori N; Postiglione L; Selleri C; de Paulis A
Transl Med UniSa; 2016 Nov; 15():34-41. PubMed ID: 27896225
[TBL] [Abstract][Full Text] [Related]
2. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.
de Paulis A; Montuori N; Prevete N; Fiorentino I; Rossi FW; Visconte V; Rossi G; Marone G; Ragno P
J Immunol; 2004 Nov; 173(9):5739-48. PubMed ID: 15494526
[TBL] [Abstract][Full Text] [Related]
3.
Napolitano F; Rossi FW; Pesapane A; Varricchio S; Ilardi G; Mascolo M; Staibano S; Lavecchia A; Ragno P; Selleri C; Marone G; Matucci-Cerinic M; de Paulis A; Montuori N
Front Immunol; 2018; 9():574. PubMed ID: 29670612
[TBL] [Abstract][Full Text] [Related]
4. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.
Montuori N; Cosimato V; Rinaldi L; Rea VE; Alfano D; Ragno P
Thromb Haemost; 2013 Feb; 109(2):309-18. PubMed ID: 23238745
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts.
Rossi FW; Napolitano F; Pesapane A; Mascolo M; Staibano S; Matucci-Cerinic M; Guiducci S; Ragno P; di Spigna G; Postiglione L; Marone G; Montuori N; de Paulis A
J Immunol; 2015 Jun; 194(11):5161-73. PubMed ID: 25917089
[TBL] [Abstract][Full Text] [Related]
6. New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms.
Gorrasi A; Petrone AM; Li Santi A; Alfieri M; Montuori N; Ragno P
Cells; 2020 Nov; 9(12):. PubMed ID: 33255171
[TBL] [Abstract][Full Text] [Related]
7. Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.
Montuori N; Pesapane A; Rossi FW; Giudice V; De Paulis A; Selleri C; Ragno P
Transl Med UniSa; 2016 Nov; 15():15-21. PubMed ID: 27896223
[TBL] [Abstract][Full Text] [Related]
8. The urokinase receptor. A cell surface, regulated chemokine.
Blasi F
APMIS; 1999 Jan; 107(1):96-101. PubMed ID: 10190285
[TBL] [Abstract][Full Text] [Related]
9. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
10. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.
Fazioli F; Resnati M; Sidenius N; Higashimoto Y; Appella E; Blasi F
EMBO J; 1997 Dec; 16(24):7279-86. PubMed ID: 9405357
[TBL] [Abstract][Full Text] [Related]
11. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.
Resnati M; Pallavicini I; Wang JM; Oppenheim J; Serhan CN; Romano M; Blasi F
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1359-64. PubMed ID: 11818541
[TBL] [Abstract][Full Text] [Related]
12. An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.
Mazzieri R; D'Alessio S; Kenmoe RK; Ossowski L; Blasi F
Mol Biol Cell; 2006 Jan; 17(1):367-78. PubMed ID: 16267271
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
14. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.
Alfano D; Franco P; Stoppelli MP
Front Cell Dev Biol; 2022; 10():818616. PubMed ID: 35493073
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
Rasch MG; Pass J; Illemann M; Høyer-Hansen G; Lund IK
J Immunol Methods; 2008 Nov; 339(1):55-65. PubMed ID: 18761343
[TBL] [Abstract][Full Text] [Related]
18. Urokinase induces survival or pro-apoptotic signals in human mesangial cells depending on the apoptotic stimulus.
Tkachuk N; Kiyan J; Tkachuk S; Kiyan R; Shushakova N; Haller H; Dumler I
Biochem J; 2008 Oct; 415(2):265-73. PubMed ID: 18564064
[TBL] [Abstract][Full Text] [Related]
19. The urokinase receptor is required for human monocyte chemotaxis in vitro.
Gyetko MR; Todd RF; Wilkinson CC; Sitrin RG
J Clin Invest; 1994 Apr; 93(4):1380-7. PubMed ID: 8163642
[TBL] [Abstract][Full Text] [Related]
20. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
